Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liushan Chen
Institutions:
Guangzhou University of Chinese Medicine,
Guangdong Provincial Hospital of Chinese Medicine
Observed institutions:
Guangzhou University of Chinese Medicine,
Hong Kong Polytechnic University,
Guangdong Pharmaceutical University,
Guangdong Provincial Hospital of Chinese Medicine,
ByteDance (China)
ORCID:
0000-0003-0414-4987
Observed ORCID:
0000-0003-0414-4987
OpenAlex ID:
A5080657085
Contract-based program repair without the contracts
2017
·
Liushan Chen
, Yu Pei
, et al.
·
IEEE/ACM International Conference on Automated Software Engineering (ASE)
·
148
Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation
2021
·
Liushan Chen
, Linghao Qin
, et al.
·
Cell Biology International
·
43
Contract-Based Program Repair Without The Contracts: An Extended Study
2020
·
Liushan Chen
, Yu Pei
, et al.
·
IEEE Transactions on Software Engineering
·
27
Restore: Retrospective Fault Localization Enhancing Automated Program Repair
2020
·
Tongtong Xu
, Liushan Chen
, et al.
·
IEEE Transactions on Software Engineering
·
24
PDF
10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling
2023
·
Yuqi Liang
, Guosong Wu
, et al.
·
Drug Design Development and Therapy
·
19
PDF
Program Repair With Repeated Learning
2022
·
Liushan Chen
, Yu Pei
, et al.
·
IEEE Transactions on Software Engineering
·
18
Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness
2023
·
Ping Huang
, Huachao Li
, et al.
·
Translational Cancer Research
·
13
PDF
Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway
2025
·
Yingchao Wu
, Liushan Chen
, et al.
·
Frontiers in Pharmacology
·
12
PDF
Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment
2024
·
Qian Zuo
, Yingchao Wu
, et al.
·
Heliyon
·
9
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p
2024
·
Liushan Chen
, Lingling Ye
, et al.
·
Scientific Reports
·
8
PDF
Effect of quercetin on the progression of breast cancer in mice with chronic stress by regulating the polarization of microglia
2024
·
Tianyu Luo
, Yuqi Liang
, et al.
·
Journal of Functional Foods
·
6
Senkyunolide H reverses depression-induced breast cancer progression by regulating CXCR2
2025
·
Yingchao Wu
, Jiaqi Cui
, et al.
·
Natural Products and Bioprospecting
·
5
PDF
A novel PPARβ/FFA1 dual agonist Y8 promotes diabetic wound healing
2023
·
Sujuan Guan
, Tingting Hu
, et al.
·
European Journal of Pharmacology
·
4
Effect of HER2-Low Expression on the Efficacy of CDK4/6 Inhibitors in Breast Cancer: A Meta-Analysis
2025
·
Lingling Ye
, Yan Dai
, et al.
·
Clinical Breast Cancer
·
3
Effect of HER2-low expression on the efficacy of CDK4/6 inhibitors in breast cancer: A meta-analysis.
2024
·
Lingling Ye
, Yan Dai
, et al.
·
Journal of Clinical Oncology
·
2
Exploring the predictive “psycho-biomarkers” for checkpoint immunotherapy in cancer
2025
·
Qian Zuo
, Jieting Chen
, et al.
·
Frontiers in Immunology
·
1
PDF
Effect of neratinib on HER2 mRNA stability via hsa-miR-23a-5p and efficacy of CDK4/6 inhibitors in HER2-low breast cancer.
2024
·
Liushan Chen
, Lingling Ye
, et al.
·
Journal of Clinical Oncology
·
1
Quercetin reverses the breast cancer-promoting effects of depression by targeting PPARγ
2026
·
Yingchao Wu
, Yuqi Liang
, et al.
·
Chinese Journal of Natural Medicines
Towards an initial understanding of the fixing power of object-oriented automated program repair
2017
·
Liushan Chen
Show more works
View as search
Works count:
19
Citation count:
343
H-index:
9
I10-index:
8
Year
Topic
Type